View in EDS

Response to "Comment on 'Dupilumab Beyond the Airway: Decreased Morbidity in a Real-World Analysis'".

Saved in:

Bibliographic Details
Title:	Response to "Comment on 'Dupilumab Beyond the Airway: Decreased Morbidity in a Real-World Analysis'".
Authors:	Anisman EJ; Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Short S; Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Tam E; Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Bitner BF; Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Alani A; Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Rosen M; Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Rabinowitz M; Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Evertz DP; Department of Pulmonary and Critical Care Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Toskala E; Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Nyquist GG; Department of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
Source:	International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2026 Apr; Vol. 16 (4), pp. 434-435. Date of Electronic Publication: 2026 Mar 07.
Publication Type:	Letter
Journal Info:	Publisher: Published for ARS-AAOA by Wiley-Blackwell Country of Publication: United States NLM ID: 101550261 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6984 (Electronic) Linking ISSN: 20426976 NLM ISO Abbreviation: Int Forum Allergy Rhinol Subsets: MEDLINE; In Process
Database:	MEDLINE Ultimate

Description
ISSN:	2042-6984
DOI:	10.1002/alr.70138